CD163 and chronic myelogenous leukemia, BCR-ABL1 positive: Table 2 shows that after adjusting for covariates (log BMI, log AST, log TG, CML, log TIBC, and log Aggregation), only log-transformed AST (β = 0.250; 95% CI: 0.023~0.477, p = 0.031), and log-transformed RBC aggregation (β = 0.332; 95% CI: 0.035~0.628, p = 0.048) remained significantly correlated with serum sCD163 levels (model 2).